Company Filing History:
Years Active: 1977-1981
Title: **The Innovative Mind of Lars-Olov Andersson**
Introduction
Lars-Olov Andersson, a notable inventor based in Knivsta, Sweden, has made significant contributions to the field of pharmaceuticals through his innovative work. With a total of five patents to his name, Andersson is recognized for his ingenuity and dedication to enhancing medical treatments.
Latest Patents
Among his latest patents, Andersson has developed "Heparin fragments having selective anticoagulation activity," which focuses on heparin fragments containing 14-18 sugar units. The key component is the disaccharide unit L-iduronosyl-2-O-sulphate-N-sulpho-U-glucosamine-6-O-sulphate, with unsulphated L-iduronic acid situated 3-5 sugar units from the unreducing terminal. Furthermore, he holds patents for pharmaceutical compositions containing these heparin fragments, as well as processes for their preparation. In addition, Andersson has devised a "Method of removal of hepatitis virus," detailing how the hepatitis virus can be eliminated from contaminated biological material using preparations such as agarose gel or beaded polyacrylamide plastic combined with various hydrophobic ligands.
Career Highlights
Andersson's career has been marked by his work with various companies, including Ab Kabi and Kabi Ab, where he honed his skills in developing transformative medical solutions. His innovative mindset and technical expertise have significantly contributed to advancements in pharmaceutical sciences.
Collaborations
Throughout his career, Lars-Olov Andersson has had the privilege of working alongside talented individuals such as Erik Yngve Holmer and Gudrun M Einarsson. These collaborations have fostered a dynamic exchange of ideas, further enriching his contributions to research and innovation.
Conclusion
Lars-Olov Andersson stands as a testament to the impact of innovation in healthcare. His pioneering patents in anticoagulation and virus removal underscore his commitment to improving medical treatments. As he continues to push the boundaries of pharmaceutical science, his work will undoubtedly inspire future inventors and researchers in the field.